Investigation of betaine as a novel psychotherapeutic for schizophrenia

BACKGROUND: Betaine is known to act against various biological stresses and its levels were reported to be decreased in schizophrenia patients. We aimed to test the role of betaine in schizophrenia pathophysiology, and to evaluate its potential as a novel psychotherapeutic. METHODS: Using Chdh (a ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohnishi, Tetsuo, Balan, Shabeesh, Toyoshima, Manabu, Maekawa, Motoko, Ohba, Hisako, Watanabe, Akiko, Iwayama, Yoshimi, Fujita, Yuko, Tan, Yunfei, Hisano, Yasuko, Shimamoto-Mitsuyama, Chie, Nozaki, Yayoi, Esaki, Kayoko, Nagaoka, Atsuko, Matsumoto, Junya, Hino, Mizuki, Mataga, Nobuko, Hayashi-Takagi, Akiko, Hashimoto, Kenji, Kunii, Yasuto, Kakita, Akiyoshi, Yabe, Hirooki, Yoshikawa, Takeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642071/
https://www.ncbi.nlm.nih.gov/pubmed/31255657
http://dx.doi.org/10.1016/j.ebiom.2019.05.062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642071/
https://www.ncbi.nlm.nih.gov/pubmed/31255657
http://dx.doi.org/10.1016/j.ebiom.2019.05.062

Ejemplares similares